Omeicos Therapeutics, a biopharmaceutical spinout of research institute Max Delbrück Center for Molecular Medicine, achieved a first close of its series B round at €8.3m ($8.7m) on Wednesday.
The round was co-led by Vesalius Biocapital and plant construction company SMS Group.
German state-owned development bank KFW and public-private partnership High-Tech Gründerfonds (HTGF) and Ascension, a tech transfer office for a range of German universities, hospitals and institutes, also participated, as did VC Fonds Technologie Berlin, Falck Revocable Trust…
- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Omeicos is treated to $8.7m
Mar 3, 2017 •
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.More featured content
Can University of Kentucky researchers bring new flavours to whisky? The University of Kentucky has formed an industry-university partnership to advance aspects such as sustainable agriculture in the whiskey distilling industry.Can University of Kentucky researchers bring new flavours to whisky?
The University of Kentucky has formed an industry-university partnership to advance aspects such as sustainable agriculture in the whiskey distilling industry.
Make sure UK proof-of-concept funds go beyond Golden Triangle, say experts The £40m recently allocated by the UK government to proving university research is commercially viable shouldn't just benefit Oxford, Cambridge and London say sector pundits.Make sure UK proof-of-concept funds go beyond Golden Triangle, say experts
The £40m recently allocated by the UK government to proving university research is commercially viable shouldn't just benefit Oxford, Cambridge and London say sector pundits.
Most top UK universities adopt lower spinout equity Many of the UK's universities have adopted recommendations to lower equity stakes in the companies they commercialise to at or below 25%.Most top UK universities adopt lower spinout equity
Many of the UK's universities have adopted recommendations to lower equity stakes in the companies they commercialise to at or below 25%.
About us
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.